These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Beta-blockaders for better or for worth--still a good alternative in hypertension]. Bengtsson C; Sigurdsson JA Lakartidningen; 2009 Jan 28-Feb 3; 106(5):298-9. PubMed ID: 19271463 [No Abstract] [Full Text] [Related]
45. Re: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination. Vivencio B Curr Med Res Opin; 2009 Sep; 25(9):2267-8; author reply 2268-9. PubMed ID: 19630488 [No Abstract] [Full Text] [Related]
46. Antihypertensive treatment and risk of cardiovascular complications: is the cure worse than the disease? Ibsen H J Hypertens; 2009 Feb; 27(2):221-3. PubMed ID: 19155778 [No Abstract] [Full Text] [Related]
48. [Treatment of hypertension. High safety of first choice agents is a requirement]. Beermann B; Lithell H Lakartidningen; 1991 Jan; 88(5):305-6. PubMed ID: 1997764 [No Abstract] [Full Text] [Related]
49. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study. Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428 [TBL] [Abstract][Full Text] [Related]
51. Prevalence and management of hypertension in primary care in Portugal. Insights from the VALSIM study. Cortez-Dias N; Martins S; Belo A; Fiuza M; Rev Port Cardiol; 2009 May; 28(5):499-523. PubMed ID: 19650569 [TBL] [Abstract][Full Text] [Related]
52. [Antihypertensive agents reduce the risk of apoplexy with 30-40%]. Olsen TS Ugeskr Laeger; 2006 Oct; 168(43):3736; author reply 3737. PubMed ID: 17128492 [No Abstract] [Full Text] [Related]
53. Reserpine: a tragic victim of myths, marketing, and fashionable prescribing. Fraser HS Clin Pharmacol Ther; 1996 Oct; 60(4):368-73. PubMed ID: 8873684 [No Abstract] [Full Text] [Related]
54. [Should we treat all the hypertensives?]. Krivitzky A; N'Guyen G Rev Infirm; 1993 Mar; 43(6):32-5. PubMed ID: 8511491 [No Abstract] [Full Text] [Related]
55. Influencing the natural history of hypertension: is it the blood pressure achieved, the drug, or the drug dose? Yuzefpolskaya M J Hypertens; 2009 Feb; 27(2):437-8; author reply 438. PubMed ID: 19155799 [No Abstract] [Full Text] [Related]
57. Comparative evaluation of the antihypertensive activities of losartan and HM70186 during liver dysfunction. Lee S Arch Pharm Res; 2009 Jul; 32(7):965-6. PubMed ID: 19641875 [No Abstract] [Full Text] [Related]
58. Hypertension in the elderly. Part I. Birbari AE J Med Liban; 2000; 48(2):84-5. PubMed ID: 11028155 [No Abstract] [Full Text] [Related]
59. Fifty years of thiazide diuretic therapy for hypertension. Moser M; Feig PU Arch Intern Med; 2009 Nov; 169(20):1851-6. PubMed ID: 19901136 [TBL] [Abstract][Full Text] [Related]